Publicaciones en colaboración con investigadores/as de University of Tübingen (1)

2022

  1. Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

    Clinical Cancer Research, Vol. 28, Núm. 12, pp. 2555-2566